SCHEMBL5325757

SCHEMBL5325757

O=C(CNC1CCCCC1)N1CCCC1

nearest known ligand 0.61

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.61
POLB P06746 1/20 0.61
ALDH1A1 P00352 2/20 0.60
MAPT P10636 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
DPP4 P27487 13/20 0.55
FAP Q12884 6/20 0.55
DPP7 Q9UHL4 6/20 0.55
HTT P42858 1/20 0.53
DPP8 Q6V1X1 1/20 0.51
DPP9 Q86TI2 1/20 0.51
EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29375817 1.00 KDM4E (0.61) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL5480089 0.98 KDM4E (0.59) KDM4EPOLBALDH1A1MAPTTDP1
Hydrochloric Acid SCHEMBL6175383 0.96 KDM4E (0.58) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL15780138 0.92 DPP4 (0.53) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL6823891 0.86 KDM4E (0.49) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL12832457 0.86 ALDH1A1 (0.62) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL31702624 0.86 ALDH1A1 (0.55) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL8288251 0.85 DPP4 (0.64) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL13716085 0.84 KDM4E (0.50) KDM4EPOLBALDH1A1MAPTTDP1
SCHEMBL24322523 0.83 KDM4E (0.53) KDM4EPOLBALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3931489-B1 FLUIDIZED BED GAS DISTRIBUTION NOZZLE AND FLUIDIZED BED REACTOR DOOSAN LENTJES GMBH (DE) 2024-07-10 EP claimed
US-20230235878-A1 FLUIDIZED BED GAS DISTRIBUTION NOZZLE AND FLUIDIZED BED REACTOR DOOSAN LENTJES GMBH (DE) 2023-07-27 US claimed
CN-115667800-A Fluidized bed gas distribution nozzle and fluidized bed reactor 斗山能捷斯有限责任公司 2023-01-31 CN claimed
WO-2022223641-A1 POROUS BURNER WITH VOLUMETRIC RADIATIVE COOLING AND METHOD OF OPERATING THE SAME TRIANGLE RESOURCE HOLDING AG (CH) 2022-10-27 WO claimed
EP-4080117-A1 POROUS BURNER WITH VOLUMETRIC RADIATIVE COOLING Triangle Resource Holding AG (CH) 2022-10-26 EP claimed
CN-121831275-B Power module capacitor capacitance value estimation method, device, medium and equipment 南方电网科学研究院有限责任公司 2026-05-12 CN disclosed
EP-3817770-B1 ANTI-STEAP1 ANTIGEN-BINDING PROTEIN AMGEN INC (US) 2026-05-06 EP disclosed
US-12604442-B2 Power module, particularly for power electronics of a vehicle ROBERT BOSCH GMBH (DE) 2026-04-14 US disclosed
EP-4664228-B1 A CONTROLLER FOR AN AUTOMATED STORAGE AND RETRIEVAL SYSTEM AUTOSTORE TECH AS (NO) 2026-03-25 EP disclosed
EP-4664228-A1 A CONTROLLER FOR AN AUTOMATED STORAGE AND RETRIEVAL SYSTEM AutoStore Technology AS (NO) 2025-12-17 EP disclosed
EP-4662689-A1 MULTI-BEAM CHARGED PARTICLE MICROSCOPE WITH A DETECTION UNIT FOR FAST COMPENSATION OF CHARGING EFFECTS Carl Zeiss MultiSEM GmbH (DE) 2025-12-17 EP disclosed
US-20250349500-A1 MULTI-BEAM CHARGED PARTICLE MICROSCOPE DESIGN WITH A DETECTION UNIT FOR FAST COMPENSATION OF CHARGING EFFECTS CARL ZEISS MULTISEM GMBH (DE) 2025-11-13 US disclosed
EP-2663312-B1 IRAK INHIBITORS AND USES THEREOF NIMBUS IRIS INC (US) 2017-10-11 EP disclosed
WO-2007127204-A2 METHODS AND COMPOSITIONS RELATING TO IMMUNOSTIMULATION DARA BIOSCIENCES, INC. (US) 2007-11-08 WO disclosed
WO-2007117419-A2 METHODS AND COMPOSITIONS RELATING TO POST-PROLYL CLEAVING ENZYME INHIBITORS DARA BIOSCIENCES, INC. (US) 2007-10-18 WO disclosed
EP-1465891-A4 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARM INC (US) 2005-08-17 EP disclosed
US-20050070719-A1 Inhibitors of dipeptidyl peptidase iv GUILFORD PHARMACEUTICALS 2005-03-31 US disclosed
EP-1465891-A2 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARMACEUTICALS INC. (US) 2004-10-13 EP disclosed
WO-2003057666-A2 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARMACEUTICALS (US) 2003-07-17 WO disclosed
WO-2003057144-A2 CHANGE INHIBITORS OF DIPEPTIDYL PEPTIDASE IV GUILFORD PHARMACEUTICALS (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12604442-B2 Power module, particularly for power electronics of a vehicle EPHA8, EPHB3, EPHA1 KDM4E 4782/4885POLB 110/4885ALDH1A1 4499/4885
US-20050070719-A1 Inhibitors of dipeptidyl peptidase iv DPP4, DPP3, DPP7 KDM4E 796/4885POLB 3990/4885ALDH1A1 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.